Pangandaran Unit for Health Research and Development, National Institute of Health Research and Development, Ministry of Health of Indonesia, Pangandaran, West Java, Indonesia.
National, Ministry of Health of Indonesia, National Institute of Health Research and Development, Jakarta, Indonesia.
BMC Public Health. 2021 Aug 13;21(1):1548. doi: 10.1186/s12889-021-11602-1.
Poor access to health care providers was among the contributing factors to less prompt and ineffective malaria treatment. This limitation could cause severe diseases in remote areas. This study examined the sub-national disparities and predictors in accessing anti-malarial drug treatment among adults in Eastern Indonesia.
The study analyzed a subset of the 2018 National Basic Health Survey conducted in all 34 provinces in Indonesia. We extracted socio-demographic data of 4655 adult respondents diagnosed with malaria in the past 12 months in five provinces in Eastern Indonesia. The association between socio-demographic factors and the access to anti-malarial drug treatment was assessed using logistic regression.
Over 20% of respondents diagnosed with malaria within last 12 months admitted that they did not receive anti-malarial drug treatment (range 12-29.9%). The proportion of untreated cases was 12.0% in East Nusa Tenggara, 29.9% in Maluku, 23.1% in North Maluku, 12.7% in West Papua, and 15.6% in Papua. The likelihood of receiving anti-malarial drug treatment was statistically lower in Maluku (adjusted OR = 0.258; 95% CI 0.161-0.143) and North Maluku (adjusted OR = 0.473; 95% CI 0.266-0.840) than those in Eastern Nusa Tenggara (reference). Urban respondents were less likely to receive malaria treatment than rural (adjusted OR = 0.545; 95% CI 0.431-0.689).
This study found that there were sub-national disparities in accessing anti-malarial drug treatment in Eastern Indonesia, with a high proportion of untreated malaria cases across the areas. Findings from this study could be used as baseline information to improve access to anti-malarial drug treatment and better target malaria intervention in Eastern Indonesia.
医疗服务提供者获取途径有限是导致疟疾治疗不及时和无效的因素之一。这种局限性可能导致偏远地区出现严重疾病。本研究调查了印度尼西亚东部地区成年人获得抗疟药物治疗方面的国家以下层面的差异和决定因素。
本研究分析了 2018 年在印度尼西亚所有 34 个省份进行的国家基本卫生调查的一个子集。我们提取了在印度尼西亚东部五个省份过去 12 个月内被诊断患有疟疾的 4655 名成年受访者的社会人口学数据。使用逻辑回归评估社会人口学因素与获得抗疟药物治疗之间的关联。
在过去 12 个月内被诊断患有疟疾的受访者中，超过 20%的人承认他们没有接受抗疟药物治疗（范围为 12-29.9%）。未治疗病例的比例在东努沙登加拉为 12.0%，马鲁古为 29.9%，北马鲁古为 23.1%，西巴布亚为 12.7%，巴布亚为 15.6%。与东努沙登加拉（参考）相比，马鲁古（调整后的 OR=0.258；95%CI 0.161-0.143）和北马鲁古（调整后的 OR=0.473；95%CI 0.266-0.840）接受抗疟药物治疗的可能性较低。城市受访者接受疟疾治疗的可能性低于农村（调整后的 OR=0.545；95%CI 0.431-0.689）。
本研究发现，印度尼西亚东部地区在获得抗疟药物治疗方面存在国家以下层面的差异，各个地区都有大量未治疗的疟疾病例。本研究的结果可以作为基线信息，以改善获得抗疟药物治疗的机会，并更好地针对印度尼西亚东部的疟疾干预措施。
